Jason Sheehan: The role of angiogenesis inhibitors on glioblastoma management
Jason Sheehan, Professor of Neurosurgery at the University of Virginia, shared a post on X about a recent paper by him and colleagues published in Journal of Neuro-Oncology:
Authors: Ali Motamed-Sanaye, Ali Mortezaei, Amir Afshari, Zahra Saadatian, Amir Faraji, Jason Sheehan and Ali Mohammad Mokhtari.
“In Journal of Neuro-Oncology, a new study arising from research by me and other colleagues details the role of angiogenesis inhibitors on glioblastoma management.”
Ali Mortezaei, Research Assistant at Ghaem Hospital, shared this post, adding:
“Grateful to Dr. Jason Sheehan and Dr. Amir Faraji for their invaluable contributions and supervision on this important study, advancing our understanding of angiogenesis inhibitors in GBM management.”
More posts featuring Jason Sheehan.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023